Add to watchlist

Cabaletta Bio, Inc. (CABA)

Last Price$1.7(7.7%)

Market Cap$85.9M

#CABA Dividend Yield

#CABA Dividend Per Share

#CABA Dividend Payout Ratio

#Competing with CABA Dividend

Overview

Ratings

Intrinsic Value

Valuation

Growth

Profitability

Health

Capital allocation

Momentum

Earnings

Dividends

Company name	Market Cap	Dividend Payout Ratio (LTM)	Cash Flow Payout Ratio (LTM)	DPS growth 1Y	DPS growth 3Y	DPS growth 10Y	Dividend Yield	Yield on Cost (1Y)	Yield on Cost (5Y)
Cabaletta Bio, Inc.CABA CABA	$85.9M	0.0%	0.0%	N/A	N/A	(100.0%)	0.0%	0.0%	0.0%
Novo Nordisk A/SNVO NVO	$402.0B	43.7%	63.0%	40.6%	29.5%	17.6%	1.5%	1.1%	4.5%
Vertex Pharmaceuticals IncorporatedVRTX VRTX	$125.5B	0.0%	0.0%	N/A	(100.0%)	N/A	0.0%	0.0%	0.0%
Regeneron Pharmaceuticals, Inc.REGN REGN	$74.0B	0.0%	0.0%	N/A	N/A	(100.0%)	0.0%	0.0%	0.0%
argenx SEARGX ARGX	$38.1B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Alnylam Pharmaceuticals, Inc.ALNY ALNY	$31.3B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BioNTech SEBNTX BNTX	$27.1B	0.0%	0.0%	(100.0%)	N/A	N/A	0.0%	0.0%	0.0%
Incyte CorporationINCY INCY	$14.8B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
Summit Therapeutics Inc.SMMT SMMT	$14.6B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
United Therapeutics CorporationUTHR UTHR	$14.0B	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%
BeiGene, Ltd.BGNE BGNE	$1,846.9M	0.0%	0.0%	N/A	N/A	N/A	0.0%	0.0%	0.0%